…
| Funding Opportunity Number: |
PA-13-141 |
| Opportunity Category: |
Discretionary |
| Funding Instrument Type: |
Grant |
| Category of Funding Activity: |
Food and Nutrition
Health |
| CFDA Number: |
93.847
93.866 |
| Eligible Applicants |
State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Agency Name: |
HHS-NIH11 |
| Closing Date: |
May 07, 2016 |
| Award Ceiling: |
|
| Expected Number of Awards: |
|
| Creation Date: |
Mar 14, 2013 |
| Funding Opportunity Description: |
This Funding Opportunity Announcement (FOA) invites applications that propose basic, clinical, translational and outcomes research on acute kidney injury (AKI) in older persons. Applications may focus on the 1) epidemiology, etiology and risk factors for AKI in older adults, 2) pathophysiology of AKI in the aging kidney and its impact on chronic kidney disease (CKD) and other organ disease 3) early detection, diagnosis and monitoring of AKI, and 4) prevention, treatment and management strategies of AKI in older patients with the goal of improving short- and long-term outcomes including morbidity, mortality, progression of CKD, functional independence and quality of life. Research supported by this initiative should enhance knowledge of the increasing incidence of AKI in older persons and its consequences and provide evidence-based guidance in the diagnosis, prevention, and treatment of AKI in this expanding segment of the population. Studies in both human subjects and animal models are appropriate under this FOA as warranted by the study questions. |
|
Read more
{iframe}http://grants.nih.gov/grants/guide/pa-files/PA-13-141.html{/iframe}
